AAVP Biosystems
New York
New York
United States
Website: http://www.aavpbiosystems.com/
Email: infor@aavpbiosystems.com
About AAVP Biosystems
AAVP Biosystems is an early stage biotechnology company developing a targeted gene delivery vector that aims to direct therapy selectively to tumor cells while sparing normal cells and tissue.LEADERSHIP:
Founders: Renata Pasqualini, Steven Libutti, Wadih Arap, and Juri G. Gelovani
CEO: Jason Rifkin
CMO: Mark Shapiro
CFO: Lisa Velardo
3 articles about AAVP Biosystems
-
AAVP Biosystems, Inc. Now Named PhageNova Bio, Inc. and Renata Pasqualini, PhD, Appointed as Chief Scientific Officer
11/1/2018
AAVP Biosystems, Inc. a developmental stage gene delivery company initially focused on the pursuit of a new therapy for cancer indications, is now named PhageNova Bio, Inc.
-
AAVP Biosystems Forms Medical Advisory Board
10/16/2017
AAVP Biosystems, a development stage gene therapy company focused on the pursuit of new targeted therapeutics for cancer indications, is pleased to announce the formation of its Medical Advisory Board.
-
AAVP Biosystems Hires Mark Shapiro, M.D., Ph.D. As Chief Medical Officer
2/9/2017